Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition (Q33603605)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q62588214)
(Q28320644)
(P304) 408-416
(P407) (Q1860)
(P433) 3
(P478) 349
(P577) Thursday, March 20, 2014
(P921) (Q425088)
(P1433) (Q1500272)
(P1476) "Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition" (language: en)
(P2093) Junko Murai
Yiping Zhang
Joel Morris
Jiuping Ji
James H Doroshow
(P2860) (Q37701295)
(Q37623863)
(Q37574005)
(Q28487036)
(Q37499042)
(Q36853236)
(Q27000099)
(Q36553266)
(Q34309488)
(Q42826404)
(Q34978267)
(Q27003972)
(Q39386006)
(Q35921514)
(Q35871546)
(Q37977004)
(Q35840328)
(Q37912812)
(Q34946954)
(Q34204273)
(Q29619617)
(Q29617422)
(Q39787856)
(Q33403458)
(Q24644255)
(Q36658399)
(Q29616780)
(Q34500845)
(Q27860519)
(Q28131711)
(Q34286861)
(Q28345489)
(Q34429383)
(Q42590921)
(Q41661575)
(Q34359946)
(Q45815416)
(Q41867379)
(Q46831119)
(Q44890551)
(Q64386358)
(Q70403104)
(Q64388338)
(P4510) (Q1659584)